This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a study on the use of intravesical gentamicin coupled with Lactobacillus rhamnosus for urinary health. The total funding amount is $126,166.00, with the award date of September 1, 2024 and an ultimate completion date of August 31, 2027. The prime awardee is Medstar Health Research Institute Inc., a non-profit organization that has extensive experience conducting clinical research and providing healthcare services for federal agencies.
The grant includes a sub-award to Loyola University of Chicago Health Sciences Campus Division, a private academic medical center, to collaborate on this project. Through this federal funding, the research teams will investigate innovative approaches to improving urinary health, leveraging the expertise of both Medstar and Loyola in areas such as biomedical research, clinical care, and healthcare delivery.
Generated 1/28/25, 9:37 AM